Privacy Policy
This policy explains the data used to deliver and manage a business inquiry. Last updated 14 August 2026.
When you submit an inquiry, Medoxy receives your name, organization, email, phone number, country if supplied, inquiry type, product interest, message, and consent selection. Please do not include patient records, clinical details, or other sensitive personal information.
The service may process basic request and device information needed for security, rate limiting, hosting, and troubleshooting.
Medoxy currently uses Vercel Web Analytics to measure page visits and website usage. Vercel processes limited request, device, and usage information on Medoxy's behalf to provide those measurements. If Google Analytics is enabled through the website configuration, Google may also process website usage information under its own privacy terms.
Inquiry information is used to validate and deliver your request, contact you about it, route it to the relevant business function, protect the service from abuse, keep necessary business records, and meet applicable obligations.
The form sends an accepted inquiry through the delivery service configured by Medoxy, such as an email provider or secure webhook. Hosting, communications, analytics, professional advisers, or authorities may process relevant information when needed to operate the site, handle the request, protect legal rights, or comply with applicable requirements.
Medoxy does not sell the personal information submitted through its inquiry form. Information is not shared for an unrelated purpose merely because an inquiry was submitted.
Inquiry information is kept only for as long as reasonably needed to handle the request, maintain necessary business or security records, resolve disputes, and satisfy applicable requirements. Retention can differ according to the inquiry and any resulting relationship.
Medoxy and its service providers use reasonable administrative and technical measures, but no internet transmission or storage system can be guaranteed completely secure. A provider may process data from infrastructure outside your location subject to its safeguards and applicable requirements.
You can ask about, correct, or request deletion of inquiry information by contacting Medoxyhealthcarellp@gmail.com. A request may be limited where information must be retained for a legitimate business, security, dispute, or legal reason. You can also use the listed email address or phone number instead of the web form.
The website may link to social networks, official references, maps, and other third-party services. Their privacy practices apply when you open or interact with those services.
This policy may be updated when the website's collection or delivery practices change. Material revisions should be reflected on this page. Last updated 14 August 2026.
Medoxy Healthcare Pvt Ltd is a B2B pharmaceutical trading company based in Gurgaon, Haryana, India, focused on a gastroenterology product catalogue for distributors, stockists, hospitals, institutions, and other qualified healthcare businesses. The product catalogue lists brand names, compositions, dosage forms, and pack sizes across categories such as proton pump inhibitor combinations, antispasmodics, ursodeoxycholic acid, rifaximin, probiotics, antacid and alginate suspensions, and nutritional supplements.
Catalogue entries include Benzispa SR (Mebeverine Hydrochloride Sustained Release), Benzispa Plus (Mebeverine + Chlordiazepoxide), Esomizole-D (Esomeprazole (EC) + Domperidone (SR)), Ursofiz 300 (Ursodeoxycholic Acid IP 300 mg), Ushield (Sucralfate + Oxetacaine), Esomizole-40 (Esomeprazole 40 mg with Sodium Bicarbonate as buffer), Edoflora (Lyophilized Saccharomyces boulardii 250 mg), Menzovit (Multivitamin, Multimineral, Antioxidants, Iron & Zinc), Finozyme Q10 (Coenzyme Q10 + L-Arginine + Omega-3 fatty acid + Selenium + Lycopene), Esomizole-IT (Esomeprazole (EC) + Itopride (SR)), Ursofiz 450 (Ursodeoxycholic Acid Sustained Release), U Raft (Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate), Rifadoxy 400 (Rifaximin IP 400 mg) and Rifadoxy 550 (Rifaximin IP 550 mg). Names, compositions, images, packaging, and availability may change or differ by market. Verify the exact product and current documents before any regulatory, procurement, or commercial decision.
1. Website content is provided for business and informational purposes only and is not a substitute for professional medical advice, diagnosis, treatment, or approved prescribing information. Patients should consult a qualified healthcare professional.
2. This website does not sell medicines online, display pricing, or accept consumer orders. A listing or inquiry response is not an offer of supply or a guarantee of availability. Terms apply.
3. References to quality, compliance, or external guidelines do not by themselves establish a particular licence, approval, or certification. Evidence applicable to a defined transaction can be requested through the trade inquiry form. See Trade & Quality and Compliance for more information.
Articles on the Healthcare Insights blog follow our content policy. Personal data submitted through inquiry forms is handled as described in the privacy policy.